Market Access Pathway for a Schizophrenia Drug
Task:
Define a winning commercial model
Task:
Define a winning commercial model
Client:
Arthur D. Little
Region:
The biggest CIS market
Project scope:
- Market landscape analysis.
- Pricing & Reimbursement overview.
- Treatment practices and available infrastructure.
- Prescribing and distribution channels for LAIs.
- National Formulary system and stakeholders.
- Epidemiology and infrastructure study.
- Analysis of established treatment practices.
- Understanding the patients' pathways.
Market analysis:
- Collection of statistical, medical, epidemiological and economic data.
- Study of the local market of antipsychotic drugs by country's core sales channels: hospital and retail.
- Analysis of the potential of each sales channel: private, public.
- Elaboration of the marketing authorization process in the country.
- Research on the dynamics of LAIs prescription in the country by core regions.
- Analysis of the unmet need in LAIs in the country.
Reimbursement:
- Analysis of pricing requirements when being enlisted into the reimbursement program.
- Elaboration of the reimbursement authorization process in the country
Treatment practices and available infrastructure:
- Analysis of the treatment pathway of LAIs in the country.
- Analysis of treatment practices in inpatient and outpatient settings.
- Overview of clinical practices in the country concerning the usage/prescribing of LAIs.
- Understanding a set of established clinical practices regarding the existing treatment preferences using orals and other antipsychotic drugs.
- Building up a prescribing landscape for LAIs in the country.
- Identification of major treatment centers in the country and its regions.
- Identification of product prescribing levels by country regions: national, regional, and province.
Formulary system:
- Overview of the formulary system in the country.
- Reviewing formularies at all levels and understanding their impact on the price formation process in the country.
- Study of formulary listing requirements, and regional differences.
- Understanding the timing and costs associated with the formulary enlisting process.
- Identification of the level of formulary influence on clinical practitioners on their prescribing behavior.
Pricing study:
- The pricing structure for competitors of Target's product in the country.
- Analysis of pricing structures per each sales channel: private, public.
Deliverables:
- A complex, detailed, stage-by-stage roadmap of bringing an innovative LAI into the biggest CIS market.
- Expert interviews with experts, practicing HCPs, and KOLs.
- Overview of the local treatment landscape in schizophrenia.
Project
leads

Download
our Brochure
our Brochure